Clinical trial / 2002
Almonds dose-dependently reduced LDL cholesterol and other lipid markers in hyperlipidemic adults.
In a randomized crossover trial, 27 hyperlipidemic adults consumed isoenergetic snack supplements of full-dose almonds (73+/-3 g/day), half-dose almonds plus muffins, or full-dose muffins for one month each. Full- and half-dose almonds reduced LDL cholesterol (9.4+/-1.9%, P<0.001 and 4.4+/-1.7%, P=0.018) and LDL:HDL ratio (12.0+/-2.1%, P<0.001 and 7.8+/-2.2%, P=0.001). Full-dose almonds also lowered oxidized LDL by 14.0+/-3.8% and lipoprotein(a) by 7.8+/-3.5%, without affecting pulmonary nitric oxide.
- Study type
- Randomized crossover trial
- Who was studied
- 27 hyperlipidemic adults
- What was measured
- Blood lipids, oxidized LDL, lipoprotein(a), and pulmonary nitric oxide
THE PAPER
Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial.
Jenkins DJ, Kendall CW, Marchie A, Parker TL, Connelly PW, Qian W, Haight JS, Faulkner D, Vidgen E, Lapsley KG, Spiller GA. Circulation, 2002.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.